| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT04333628 Details | 2020-10-14 Interventional | 2/3 | 5 | Chloroquine COVID-19 | Teminated due to changes in treatment guidelines . - | |||
| NCT04212065 Details | 2020-10-14 Interventional | 4 | 0 | Buprenorphine Opioid-Related … Opioid Use Diso… | closed due to new safety concerns of subcutaneous buprenorphine in pregnant patients - | |||
| NCT04049578 Details | 2020-10-14 Interventional | 1 | 2 | Balovaptan Autism Spectrum… Autistic Disord… Child Developme… | Recent analysis of Phase II balovaptan data in paediatric ASD did not support the continuation
of this study. No new safety concerns were identified. Study was terminated with 2 participants enrolled. Due to low enrollment number patient analysis are not provided to protect participant confidentiality. | |||
| NCT03068754 Details | 2020-10-14 Interventional | 2/3 | 143 | Adrenocorticotr… Amyotrophic Lat… Motor Neuron Di… Sclerosis | As recommended by the study's independent Data and Safety Monitoring Board (DSMB) - | |||
| NCT03013127 Details | 2020-10-14 Interventional | 2 | 12 | Pembrolizumab Osteosarcoma | Inclusion of patients was stopped because ≤2 patients had clinical benefit. - | |||
| NCT02941016 Details | 2020-10-14 Interventional | 4 | 0 | Alirocumab Evolocumab Inflammation Lipid Lowering,… | Logistic reasons - | |||
| NCT03052517 2016-001560-11 Details | 2020-10-12 Interventional | 3 | 2538 | Indoleacetic Ac… Asthma | Company Decision - | |||
| NCT03862053 Details | 2020-10-09 Interventional | 4 | 0 | Ophthalmic Solu… Conjunctivitis Conjunctivitis,… Hypersensitivit… Allergic Conjun… | not enough time to complete trial;covid - | |||
| NCT03106753 Details | 2020-10-09 Interventional | 4 | 34 | Bupivacaine Terbutaline External Cephal… | Interim analysis to assess concern for spinal anesthesia and increased cesarean delivery rate. - | |||
| NCT02829372 2015-002926-38 Details | 2020-10-09 Interventional | 1 | 36 | Antibodies Antibodies, Bis… Antibodies, Mon… HER2 Expressing… | Study halted prematurely and will not resume; participants are no longer being examined or
receiving intervention - | |||
| NCT04342156 Details | 2020-10-08 Interventional | 3 | 0 | Hydroxychloroqu… COVID-19 Coronavirus Inf… Coronavirus Inf… Hydroxychloroqu… | The number of patients with COVID-19 in Singapore was coming down for the community and the
concerns about the potential side effects particularly when the baseline ECG and serum
electrolytes was not proposed. - | |||
| NCT04088266 Details | 2020-10-08 Interventional | 4 | 0 | Buprenorphine Naloxone Evaluation of Q… | Study delayed indefinetly - | |||
| NCT00152308 Details | 2020-10-08 Interventional | 4 | - | Ethanol MTOR Inhibitors Sirolimus Temsirolimus Coronary Diseas… | Slow enrolement - | |||
| NCT04561817 Details | 2020-10-06 Interventional | 2 | 0 | Ipatasertib Paclitaxel Carcinoma, Ovar… Ovarian Neoplas… | Evolving data with Ipatasertib that changes the known risk / benefit background in pursuing
future studies. - | |||
| NCT03107325 Details | 2020-10-06 Interventional | 4 | [1 Refs] | 0 | Fluorodeoxygluc… Neoplasms Childhood Neopl… | No subjects who met the study criteria agreed to participate in two years prior to the COVID-19
crisis. - | ||
| NCT00017433 Details | 2020-10-06 Interventional | 2 | - | Arsenic Trioxid… Multiple Myelom… Neoplasms, Plas… Plasmacytoma Multiple Myelom… | - - | |||
| NCT04575558 Details | 2020-10-05 Interventional | 2 | 0 | Azithromycin Hydroxychloroqu… Sars-CoV2 | Withdrawn due to lack of study centers interested in participating. - | |||
| NCT04206865 Details | 2020-10-05 Interventional | 4 | 0 | Sacubitril and … Valsartan Vasodilator Age… Cardiac Output,… Shock, Cardioge… Cardiogenic Sho… | New study initiated - | |||
| NCT02253992 2014-002241-22 Details | 2020-10-05 Interventional | 1/2 | 232 | Nivolumab Lymphoma, B-Cel… Lymphoma, Non-H… Advanced B-cell… Advanced Solid … | - - | |||
| NCT00551733 2007-004167-22 Details | 2020-10-05 Interventional | 3 | [1 Refs] | - | Albumin-Bound P… Carboplatin Paclitaxel Paclitaxel poli… Carcinoma, Non-… Lung Neoplasms Lung Cancer | - - |